User profiles for Christopher M. Booth
Christopher M. Booth MD FRCPCProfessor of Oncology, Queen's University Verified email at kgh.kari.net Cited by 18844 |
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
CM Booth, LM Matukas, GA Tomlinson, AR Rachlis… - Jama, 2003 - jamanetwork.com
ContextSevere acute respiratory syndrome (SARS) is an emerging infectious disease that
first manifested in humans in China in November 2002 and has subsequently spread …
first manifested in humans in China in November 2002 and has subsequently spread …
Mortality due to cancer treatment delay: systematic review and meta-analysis
…, GA Paulin, E Harvey-Jones, DE O'Sullivan, CM Booth… - bmj, 2020 - bmj.com
Objective To quantify the association of cancer treatment delay and mortality for each four
week increase in delay to inform cancer treatment pathways. Design Systematic review and …
week increase in delay to inform cancer treatment pathways. Design Systematic review and …
Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis
…, WJ Mackillop, W Kong, WD King, CM Booth - Jama, 2011 - jamanetwork.com
Context Adjuvant chemotherapy (AC) improves survival among patients with resected
colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. …
colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. …
[HTML][HTML] Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
During the COVID-19 global pandemic, the cancer community faces many difficult questions.
We will first discuss safety considerations for patients with cancer requiring treatment in …
We will first discuss safety considerations for patients with cancer requiring treatment in …
Is this patient dead, vegetative, or severely neurologically impaired?: assessing outcome for comatose survivors of cardiac arrest
ContextMost survivors of cardiac arrest are comatose after resuscitation, and meaningful
neurological recovery occurs in a small proportion of cases. Treatment can be lengthy, …
neurological recovery occurs in a small proportion of cases. Treatment can be lengthy, …
[HTML][HTML] Priorities for cancer research in low-and middle-income countries: a global perspective
Cancer research currently is heavily skewed toward high-income countries (HICs), with little
research conducted in, and relevant to, the problems of low- and middle-income countries (…
research conducted in, and relevant to, the problems of low- and middle-income countries (…
Cancer in sub-Saharan Africa: a lancet oncology commission
…, S Avery, P Barango, N Bih, CM Booth… - The Lancet …, 2022 - thelancet.com
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer
incidence and mortality. Without rapid interventions, data estimates show a major increase in …
incidence and mortality. Without rapid interventions, data estimates show a major increase in …
The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population‐based study in Ontario, Canada
CM Booth, G Li, J Zhang‐Salomons, WJ Mackillop - Cancer, 2010 - Wiley Online Library
BACKGROUND: Lower socioeconomic status (SES) is associated with worsened cancer
survival. The authors evaluate the impact of SES on stage of cancer at diagnosis and survival in …
survival. The authors evaluate the impact of SES on stage of cancer at diagnosis and survival in …
Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology guideline): American Society of Clinical Oncology clinical practice …
Purpose To endorse the European Association of Urology guideline on muscle-invasive (MIBC)
and metastatic bladder cancer. The American Society of Clinical Oncology (ASCO) has …
and metastatic bladder cancer. The American Society of Clinical Oncology (ASCO) has …
Evolution of the randomized clinical trial in the era of precision oncology
Importance The randomized clinical trial (RCT) in oncology has evolved since its widespread
adoption in the 1970s. In recent years, concerns have emerged regarding the use of …
adoption in the 1970s. In recent years, concerns have emerged regarding the use of …